Identification of TUBB2A by quantitative proteomic analysis as a novel biomarker for the prediction of distant metastatic breast cancer.

Conclusions: Our report is the first study to examine the distant metastatic breast cancer proteome using FFPE tissues. The depth of our dataset allowed us to discover a novel biomarker candidate and a proteomic characteristics of distant metastatic breast cancer. Distinct molecular features of various breast cancer subtypes were also established. Our proteomic data constitute a valuable resource for research on distant metastatic breast cancer. PMID: 32489334 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32489334?dopt=Abstract

Source: Clinical Genitourinary Cancer - June 4, 2020 Category: Cancer & Oncology Authors: Shin D, Park J, Han D, Moon JH, Ryu HS, Kim Y Tags: Clin Proteomics Source Type: research